Companies / Atea Pharmaceuticals, Inc.
Atea Pharmaceuticals, Inc.
Nasdaq: AVIRCIK 1593899BOSTON, MA
Financials · FY2021
Ownership
80.2M shares outstanding · as of Aug 10, 2026
Ownership
| Insiders | 3.25% | 2,605,527 |
| 10%+ / strategic | 9.74% | 7,810,000 |
| Institutions | 71.69% | 57,494,837 |
| Public float | 15.33% | 12,294,335 |
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 9
View all →| Insider | % of shares | Shares |
|---|---|---|
Corcoran AndreaSee Remarks | 1.03% | 823,576 |
Sommadossi Jean-PierreCEOPresident, CEO, and Chairman · Director | 0.96% | 767,830 |
Berger Franklin MDirector | 0.67% | 536,097 |
Hammond Janet MJChief Development Officer | 0.16% | 127,665 |
Horga Maria ArantxaChief Medical Officer | 0.12% | 96,086 |
Duncan Barbara GayleDirector | 0.12% | 92,350 |
Vavricka JohnChief Commercial Officer | 0.10% | 82,594 |
Foster WayneEVP, Chief Accounting Officer | 0.10% | 79,329 |
Kirsch Arthur SDirector | — | — |
Institutional holders 116
View all →| Holder | Value | % of shares |
|---|---|---|
| $40.55M | 10.87% | |
| $34.55M | 12.07% | |
| $32.33M | 8.67% | |
| $25.90M | 6.00% | |
| $15.09M | 5.27% | |
| $10.03M | 2.32% | |
| $9.41M | 2.18% | |
| $8.87M | 3.10% | |
| $7.68M | 2.06% | |
| $6.28M | 1.45% |
Activity
Jun 30, 2026View all →
InsidersInstitutions
Who's accumulating and trimming this stock (13F).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Q1 2026 as of | Two Sigma Investments, LP 13F manager | Add | Common stock | $6.02M | +1.1M +150.08% | 1,864,164 2.32% of shares | medium |
| Q2 2026 as of | BML Capital Management, LLC 13F manager | Trim | Common stock | $-2.50M | -538K -7.18% | 6,952,330 8.67% of shares | low |
| Q1 2026 as of | Millennium Management LLC 13F manager | Trim | Common stock | $-1.87M | -348K -49.88% | 349,932 0.44% of shares | low |
| Q1 2026 as of | Arrowstreet Capital, Limited Partnership 13F manager | New | Common stock | $1.13M | +211K | 210,542 0.26% of shares | low |
| Q2 2026 as of | BlackRock, Inc. 13F manager | Add | Common stock | $1.06M | +229K +2.70% | 8,720,077 10.87% of shares | low |
| Q1 2026 as of | BNP Paribas Financial Markets 13F manager | Add | Common stock | $711.5K | +132K +548.04% | 156,391 0.19% of shares | low |
| Q4 2025 as of | Bank of America Corp /De 13F manager | Trim | Common stock | $-634.9K | -178K -56.70% | 135,794 0.17% of shares | low |
| Q2 2026 as of | State Street Corporation 13F manager | Trim | Common stock | $-614.1K | -132K -7.40% | 1,652,399 2.06% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| BML Investment Partners, L.P. | Passive13G | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| AVIR | — | 04683R106 |